Barhemsys Dosage
Generic name: Amisulpride 2.5mg in 1mL
Dosage form: injection, solution
Drug class: Miscellaneous antiemetics
Medically reviewed by drugclasses.com. Last updated on Sep 26, 2022.
Recommended Dosage
The recommended adult dosage of BARHEMSYS and infusion rate by indication is shown in the table below:
Indication | Adult Dosage Regimen |
---|---|
Prevention of PONV | 5 mg as a single intravenous injection infused over 1 to 2 minutes at the time of induction of anesthesia [see Dosage and Administration (2.2)]. |
Treatment of PONV | 10 mg as a single intravenous injection infused over 1 to 2 minutes in the event of nausea and/or vomiting after a surgical procedure [see Dosage and Administration (2.2)]. |
Preparation and Administration
- Dilution of BARHEMSYS is not required before administration. BARHEMSYS is chemically and physically compatible with Water for Injection, 5% Dextrose Injection, 0.9% Sodium Chloride Injection, and Lactated Ringer's Solution (also known as Ringer's Lactate Solution, Compound Sodium Lactate Solution, and Hartmann's Solution), any of which may be used to flush an intravenous line before or after administration of BARHEMSYS.
- Protect from light. BARHEMSYS is subject to photodegradation. Administer BARHEMSYS within 12 hours of removal of the vial from the protective carton.
- Prior to administration, inspect the BARHEMSYS solution visually for particulate matter and discoloration. Discard if particulate matter or discoloration is observed.
More about Barhemsys (amisulpride)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antiemetics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.